Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × Brentuximab Vedotin × Clear all

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Triple Negative Breast Neoplasms

NCT02086604 2022-02-17

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase 1 Completed

37 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

Clinical Trials

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma